Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-25T17:27:26.709Z Has data issue: false hasContentIssue false

FC03-02 - Deep Brain Stimulation of the Nucleus Accumbens in Treatment Resistant Alcohol Addiction - a Novel Treatment Option?

Published online by Cambridge University Press:  17 April 2020

U. Mueller
Affiliation:
Psychiatry, University Hospitals Cologne, Cologne, Germany
J. Voges
Affiliation:
Stereotactic Neurosurgery, University Hospitals Cologne, Cologne, Germany
I. Galazky
Affiliation:
Neurology, University Hospitals Magdeburg, Magdeburg, University Hospitals Cologne, Cologne, Germany
M. Heldmann
Affiliation:
Neurology, University Hospitals Magdeburg, Magdeburg, University Hospitals Cologne, Cologne, Germany
H.-J. Heinze
Affiliation:
Neurology, University Hospitals Magdeburg, Magdeburg, University Hospitals Cologne, Cologne, Germany
V. Sturm
Affiliation:
Clinic for Stereotaxy and Functional Neurosurgery, University Hospitals Cologne, Cologne, Germany
B. Bogerts
Affiliation:
Psychiatry, University Hospitals Cologne, Cologne, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Treatment of alcohol addiction remains challenging, since only half of all patients achieve long-term abstinence by currently available therapies.

Objective

In the last 2 years, there have been promising reports on deep brain stimulation (DBS) of NAc in addiction (animal models, one case report of a patient with severe anxiety disorder and secondary addiction). Our group treated 5 patients with treatment resistant alcohol addiction with DBS so far. Our initial data of the first 3 patients has just been published. However, these very positive results arise from a continuous open stimulation and have not been placebo controlled.

Aims

To assess the impact of discontinuation of bilateral DBS of the NAc on craving for alcohol in patients whose addiction remitted after initiation of DBS.

Methods

Crossover, double-blinded phase of 2 × 4 weeks with sham-stimulation in one and stimulation in the other 4 weeks.

Results

Until now, one patient finished the 8 weeks of study (remaining patients will finish experiment in December 2009). In this patient, stimulation was continued in the first and stopped in the latter 4 weeks. While he experienced no changes or side effects in the first part, he showed a massive craving for alcohol one day after discontinuation, which again remitted when the experiment was stopped and the stimulator was turned on again after 3 days.

Conclusions

DBS of NAc seems to selectively alleviate craving for alcohol thus enabling patients to remain abstinent. These results justify clinical studies in larger samples of patients with treatment resistant alcohol addiction.

Type
Free Communications
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.